Cognizant Technology Solutions Corporation and TriZetto Provider Solutions, LLC
This docket consolidates claims arising from a data security breach involving Cognizant Technology Solutions and its TriZetto Provider Solutions subsidiary, which provides healthcare claims-processing and administrative technology to payers and providers, alleging unauthorized access to personal and health-related information belonging to patients whose data flowed through TriZetto's systems. Centralized in the Eastern District of Missouri in June 2026, the docket is early-stage, with 28 pending actions filed so far.
For a funder, this is another healthcare-technology-vendor breach with the now-familiar diligence structure: claim-specific analysis should identify which downstream healthcare payer or provider used TriZetto's affected systems and what categories of protected health and personal information were exposed for a given claimant, since TriZetto serves a range of healthcare-industry clients. Because the docket is still young, there is no bellwether or settlement track record yet in this proceeding, so early underwriting depends on individual claim documentation rather than docket-wide precedent.
As a data-exposure matter, medical-lien considerations in the traditional sense do not apply notwithstanding the healthcare context. For a claimant group or firm with claims tied to a specific TriZetto-affiliated payer or provider, Criterica Capital's commercial litigation finance line is the applicable structure, with terms reflecting the docket's early stage. A structural brief tracking this docket's development is available through Criterica Intelligence.
Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.
Litigation structure and resolution-risk brief on Criterica Intelligence →